Daclatasvir as a hepatitis C infection treatment option: an up-to-date evaluation
Article in Expert Opinion on Pharmacotherapy (November 2022)
The most recent citing publications are shown below. View all 36 publications that cite this research output on Dimensions.
Exposure to aflatoxin B1 and associated risk factors in hepatitis C patients in cosmopolitan city of Pakistan: facility-based study
Article in Pan African Medical Journal (January 2021)
Evaluating Drug Resistant Mutations to HCV NS3 Protease Inhibitors in Iranian Naïve Patients
Article in International Journal of Peptide Research and Therapeutics (November 2019)